Asia Pacific antidiabetics market to reach USD 28 billion by 2024|Eli Lilly, Bayer Corporation, Novartis, Johnson & Johnson, AstraZeneca, Pfizer, Bristol-Myers Squibb, Novo Nordisk, Merck, Boehringer Ingelheim
Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/504
Antidiabetics market is anticipated to surpass USD 116 billion revenue by 2023 owing to the alarming diabetes occurrence rate worldwide. International Diabetes Federation projects 552 million diabetes cases to be registered by 2030. Geriatric demographic and obesity patients are likely to exhibit higher diabetes rates and will be the main drivers of this industry accounting for 360 million diabetes cases by 2023.
Moreover, rising awareness among people about the causes and consequences of diabetes is also favoring the market growth. Diabetes as a global health concern is being addressed by the government through various campaigns to inform and educate people about the effects and consequences of this disease and thus, motivate them to take effective measures for its control. For instance, NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) has organized educational campaigns like ‘Control your diabetes for life’,‘Small Steps’, etc. to spread awareness about the importance of diabetes control.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/504
Multinational pharmaceutical companies like Pfizer, Merck, GlaxoSmithKline, Novartis, Eli Lilly, Sanofi, AstraZeneca are aiming towards expanding their market across 57.2 million people by 2025. Expanding their respective product portfolios will be the major growth strategy adopted by these players over the coming years. Generic drug manufacturers will also witness high growth opportunities in this market taking advantage of the reliance factor on low cost medicines.
North America insulin antidiabetic market share worth USD 22.2 billion in 2015, will witness a noticeable surge in the coming years, driven by factors like better healthcare facilities in terms of accessibility, high disposable income, and favorable reimbursement policies.
Insulin products will significantly grow over the coming years and will account for a revenue of USD 75 billion by 2023. Growing diabetes occurrence rates coupled with rising awareness among people about its treatment and control will drive the insulin market growth.
Browse Complete Summary of this report @ https://www.gminsights.com/industry-analysis/antidiabetics-market
Antidiabetics market is becoming highly competitive with a variety of industry participants entering into the business space. Generic drug manufacturers have high scope wherein they can drive the revenue by manufacturing biosimilar medicines. Also, the new trend where the drug manufacturers strategically tie up with social insurance systems to ensure convenient healthcare access will lead to some interesting developments in this market in terms of competition and facilities.
Chemical Analyzers Market : Regional Industry Segmentation, Analysis by Production, Consumption, Revenue and Growth Rate by 2024
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Corporate Sales, USA
Global Market Insights, Inc.
Toll Free: 1-888-689-0688
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia Pacific antidiabetics market to reach USD 28 billion by 2024|Eli Lilly, Bayer Corporation, Novartis, Johnson & Johnson, AstraZeneca, Pfizer, Bristol-Myers Squibb, Novo Nordisk, Merck, Boehringer Ingelheim here
News-ID: 1634462 • Views: 679
More Releases from Global Market Insights, Inc.
Trend in automotive application to Asia Pacific expanded polyethylene foam marke …
Of late, expanded polyethylene foam has become a trendy petrochemical product in applications, ranging from automotive, construction, packaging, protective covers and sports goods. Eliminating cost of making expensive molds and offering tremendous cushion against vibrations, shocks and abrasion are some of the upsides that have encouraged emerging economies such as India, China, Vietnam and Malaysia to infuse funds in EPE for packaging goods, boost high thermal resistance and weight
Marine Coatings Market Size, Share, Growth Demand and Top key Players like AkzoN …
Marine coatings market revenue till 2024: anti-fouling coatings are expected to account for a major share of the industry. Owing to extensive an application landscape, anti-fouling coatings are expected to account for a major share of the marine coatings market revenue over 2016-2024. Since ships are prone to damage caused by growth of subaquatic organisms on its hull, it is mandatory to use anti-fouling agents on ships and to regularly
3 Trends Fostering Global Plastic Compounding Market Size
According to a Global Market Insights, Inc., global plastic compounding market size is most probable to breach the US$56.9 billion mark by 2026. Incorporation of lightweight plastic materials for construction and automobile applications will drive the market forecast in the coming few years. Mentioned below are some recent tends fostering the industry size. Plastic compounding plays a crucial role to fulfil the growing consumer requirements by improving the performance characteristics
Sodium acetate market from medical & pharmaceuticals end-user segment is estimat …
Sodium acetate market is expected to showcase significant growth in the coming year. Sodium acetate is mainly available in anhydrous and trihydrate forms. Being less expensive than sodium acetate anhydrous, trihydrate product segment will capture about two-thirds of the overall sodium acetate industry share. Its excellent pH controlling characteristics and hydrophilic nature makes is preferable for myriad industrial applications. Sodium acetate trihydrate finds extensive application in leather & textile and
More Releases for Antidiabetics
US Antidiabetics Drug Market Outlook 2022 Report
“US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs in US * US Biosimilar Insulin Market * US Antidiabetics Drug Market Future Prospects Download Report Sample Weblink: https://www.kuickresearch.com/report-us-antidiabetics-drug-market-outlook-2022.php For Report Sample Contact: email@example.com Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin
US Antidiabetics Drug Market Outlook 2022 Report Download
“US Antidiabetics Drug Market Outlook 2022” report gives clinical and non-clinical insight on trends associated with the development of Antidiabetics drug market in US. Report helps to identify the diabetes epidemiology (Prevalence of Type 1 and 2 Diabetes) in the US market along with the associated economic burden and productivity loss. “US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs
Antidiabetics Market Intelligence with Competitive Landscape 2023
The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally. The anti-diabetics market
Global Antidiabetics Drug Market Size - Industry Analysis And Forecast
Latest industry research report on: Global Antidiabetics Drug Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Antidiabetics Drug in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1270897 Global Antidiabetics Drug market competition by top manufacturers, with production, price, revenue
US Antidiabetics Drug Market US Antidiabetics Clinical Pipeline Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin 2.2 Historical En Route towards Oral Diabetic Medication Treatments Available for Diabetes Mellitus 3.1 Non-Pharmacological Approaches for Diabetes Mellitus 3.2 Pharmacological Approaches for Diabetes Mellitus Cataloguing of Antidiabetic Agents 4.1
US To Dominate Global Antidiabetics Drug Market
“US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs in US * US Biosimilar Insulin Market * US Antidiabetics Drug Market Future Prospects For Report Sample Contact: email@example.com or +91-11-47067990 Download Report: https://www.kuickresearch.com/report-us-antidiabetics-drug-market-outlook-2022.php Report Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin